Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
europe top stories
3
×
fda
life sciences
national
3
×
national blog main
san francisco top stories
europe blog main
national top stories
new york top stories
san francisco blog main
abaloparatide
amgen
arena pharmaceuticals
billy dunn
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
colorectal cancer
detroit blog main
detroit top stories
drug prices
drug pricing
eisai
european commission
evrysdi
gene therapy
genentech
indiana blog main
indiana top stories
ionis pharmaceuticals
lorcaserin
lung cancer
new york blog main
novartis
What
drug
medicine
3
×
fda
marketing
patients
amgen
amgen’s
approval
approved
atrophy
cancer
carries
daily
developed
eisai
europe
european
evrysdi
flags
friday
green
heart
higher
home
incidence
intended
lights
liquid
lorcaserin
loss
market
muscular
new
nod
oral
osteoporosis
post
pulls
raise
risdiplam
Language
unset
Current search:
national
×
medicine
×
" europe top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
